AMPI-109

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAMPI-109
Drug Alias NameAPH-0701APH-1201APH-MP109
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVitamin D analoguesApoptosis stimulants
TargetsVitamin D receptor
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAphios Corporation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAphios Corporation
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A